<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(1)</volume><submitter>Sun K</submitter><funding>The 863 project of Young Scientist</funding><funding>State Key Clinical Specialty Construction Project (2011)</funding><funding>Major project of the people’s livelihood science and technology in Guangzhou</funding><funding>Natural Science Foundation of Guangdong Province, China</funding><funding>Science and Technology Planning Project of Guangdong Province, China</funding><funding>The National Natural Science Foundation of China</funding><funding>The Zhu jiang Star of science and technology Foundation in Guang Zhou</funding><funding>Grants from the Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases</funding><funding>Sun Yat - sen University Medical 2016 Youth Teacher Research Funding Project</funding><pubmed_abstract>OBJECTIVES:The effects of lipid metabolism disorder on renal damage have drawn much attention. Using the fatty liver index (FLI) as a validated indicator of hepatic steatosis, this study aims to provide insight about the possible links between fatty liver and the development of chronic kidney disease (CKD). SETTING:Hospital. PARTICIPANTS:We performed a population-based study on 9436 subjects aged 40 years or older. PRIMARY AND SECONDARY OUTCOME MEASURES:FLI is calculated using an algorithm based on body mass index, waist circumference, triglycerides and γ-glutamyltransferase. Increased urinary albumin excretion was defined according to the urinary albumin to creatinine ratio ranges ≥30 mg/g. CKD was defined as estimated glomerular filtration rate (eGFR) &lt;60 mL/min/1.73 m² or presence of al</pubmed_abstract><journal>BMJ open</journal><pagination>e019097</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5829809</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Fatty liver index, albuminuria and the association with chronic kidney disease: a population-based study in China.</pubmed_title><pmcid>PMC5829809</pmcid><pubmed_authors>Yan L</pubmed_authors><pubmed_authors>Lin D</pubmed_authors><pubmed_authors>Li F</pubmed_authors><pubmed_authors>Qi Y</pubmed_authors><pubmed_authors>Feng W</pubmed_authors><pubmed_authors>Ren M</pubmed_authors><pubmed_authors>Chen C</pubmed_authors><pubmed_authors>Liu D</pubmed_authors><pubmed_authors>Sun K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Fatty liver index, albuminuria and the association with chronic kidney disease: a population-based study in China.</name><description>OBJECTIVES:The effects of lipid metabolism disorder on renal damage have drawn much attention. Using the fatty liver index (FLI) as a validated indicator of hepatic steatosis, this study aims to provide insight about the possible links between fatty liver and the development of chronic kidney disease (CKD). SETTING:Hospital. PARTICIPANTS:We performed a population-based study on 9436 subjects aged 40 years or older. PRIMARY AND SECONDARY OUTCOME MEASURES:FLI is calculated using an algorithm based on body mass index, waist circumference, triglycerides and γ-glutamyltransferase. Increased urinary albumin excretion was defined according to the urinary albumin to creatinine ratio ranges ≥30 mg/g. CKD was defined as estimated glomerular filtration rate (eGFR) &lt;60 mL/min/1.73 m² or presence of al</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jan</publication><modification>2025-04-19T00:09:58.396Z</modification><creation>2019-03-26T22:46:50Z</creation></dates><accession>S-EPMC5829809</accession><cross_references><pubmed>29382678</pubmed><doi>10.1136/bmjopen-2017-019097</doi></cross_references></HashMap>